HLA TWIN 4.4.1 – Software Update

26/03/2021

At Omixon, we are committed to continuously improving our products, correcting issues, and implementing fixes for software bugs with expediency in order to minimize the effects and eliminate disruptions in our customers’ workflow. Based on early feedback regarding HLA Twin we are pleased to inform you that all reported...

EFI Annual Meeting 2021

09/03/2021

EFI 2021 | From Research To Clinical Reality The registration is already open, you can register and find more info HERE. The planned detailed program is available HERE. In order to arrange one-to-one discussions with any of our representatives, please contact them either in advance by sending an email to sales@omixon.com or on the spot...

Omixon Accelerate International Expansion in Mexico and India

25/02/2021

Omixon announced today new distribution channels in Mexico and India to further accelerate its international commercial expansion with additional launches planned throughout the remainder of 2021. We are excited to partner with ExpertLab in Mexico and with Biotron Healthcare in India to support HLA laboratories with the adoption of Next...

New Year Address from the CEO

07/01/2021

Year 2020 will enter the history books described as unprecedented, remarkable, extraordinary, or once-in-a lifetime challenge for humanity. All of us suffered from the restrictions introduced to suppress viral transmission. Many of us had loved ones affected or lost to COVID. Scientist lacked opportunities to meet, discuss and debate the...

Interview- Meet Our New FAS, Lisa Creary

29/10/2020

We are happy to announce that Lisa Creary joined Omixon as a Field Application Scientist effective October, 2020. In the following mini-interview Lisa talks about her passion, experiences and thoughts on HLA activities. Welcome Lisa! How did you become a scientist? My first experience of science dates back many moons ago...